These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10082504)
1. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group. Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Stamler J Hypertension; 1999 Mar; 33(3):887-93. PubMed ID: 10082504 [TBL] [Abstract][Full Text] [Related]
2. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological Study. The Gubbio Collaborative Study Group. Trevisan M; Laurenzi M Circulation; 1991 Nov; 84(5):2011-9. PubMed ID: 1934375 [TBL] [Abstract][Full Text] [Related]
3. Sodium-lithium countertransport and blood pressure change over time: the Gubbio study. Cirillo M; Laurenzi M; Panarelli W; Trevisan M; Dyer AR; Stamler R; Stamler J Hypertension; 1996 Jun; 27(6):1305-11. PubMed ID: 8641740 [TBL] [Abstract][Full Text] [Related]
4. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study. Laurenzi M; Cirillo M; Panarelli W; Trevisan M; Stamler R; Dyer AR; Stamler J Circulation; 1997 Feb; 95(3):581-7. PubMed ID: 9024143 [TBL] [Abstract][Full Text] [Related]
5. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study. Strazzullo P; Siani A; Cappuccio FP; Trevisan M; Ragone E; Russo L; Iacone R; Farinaro E Hypertension; 1998 Jun; 31(6):1284-9. PubMed ID: 9622143 [TBL] [Abstract][Full Text] [Related]
6. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah. Hunt SC; Williams RR; Ash KO Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():357-62. PubMed ID: 2271398 [TBL] [Abstract][Full Text] [Related]
7. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982 [TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Ragone E; Strazzullo P; Siani A; Iacone R; Russo L; Sacchi A; Cipriano P; Mancini M; Zhao G; Yuan XY; Li DY; Gong L Am J Hypertens; 1998 Aug; 11(8 Pt 1):935-41. PubMed ID: 9715785 [TBL] [Abstract][Full Text] [Related]
9. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644 [TBL] [Abstract][Full Text] [Related]
10. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. Strazzullo P; Cappuccio FP; Trevisan M; Siani A; Barba G; Ragone E; Pagano E; Mancini M J Hypertens; 1993 Aug; 11(8):815-22. PubMed ID: 8228205 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes. Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G; Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689 [TBL] [Abstract][Full Text] [Related]
12. Relationship between sodium-lithium countertransport and insulin sensitivity in mild hypertension. Herlitz H; Landin K; Widgren B J Intern Med; 1996 Mar; 239(3):235-40. PubMed ID: 8772622 [TBL] [Abstract][Full Text] [Related]
13. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients. Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312 [TBL] [Abstract][Full Text] [Related]
14. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment. Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692 [TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666 [TBL] [Abstract][Full Text] [Related]
16. Sodium lithium countertransport and blood pressure. Longitudinal findings. Trevisan M; Strazzullo P; Cappuccio F; Jossa F; Iacone R; Russo I; Farinaro E Am J Hypertens; 1996 Nov; 9(11):1132-5. PubMed ID: 8931840 [TBL] [Abstract][Full Text] [Related]
17. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Laurenzi M; Trevisan M Hypertension; 1989 May; 13(5):408-15. PubMed ID: 2722223 [TBL] [Abstract][Full Text] [Related]
18. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial. Mead PA; Wilkinson R; Thomas TH Diabetes Care; 2001 Mar; 24(3):527-32. PubMed ID: 11289480 [TBL] [Abstract][Full Text] [Related]
19. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Mead P; Wilkinson R; Thomas TH Hypertension; 1999 Dec; 34(6):1275-80. PubMed ID: 10601130 [TBL] [Abstract][Full Text] [Related]
20. A biometrical study of the relationship between sodium-lithium countertransport and triglycerides. StengÄrd JH; Zerba KE; Turner ST; Sing CF Ann Hum Genet; 1997 Mar; 61(Pt 2):121-36. PubMed ID: 9177119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]